The Psychedelic Therapies Executive Order

This Viewpoint discusses the executive order supporting the development and approval of psychedelic drugs and outlines issues surrounding their ethical and evidence-based integration into clinical care.

Authors

Holly Fernandez Lynch (ORCID: https://orcid.org/0000-0001-7813-9879)
AL McGuire
I Glenn Cohen (ORCID: https://orcid.org/0000-0002-0223-3305)

Institutions

Baylor College of Medicine (US)
Harvard University Press (US)
Bioethics International (US)
University of Pennsylvania (US)

Publication Details

Journal: JAMA
Published: 2026-07-01
DOI: https://doi.org/10.1001/jama.2026.11892
Primary Topic: Psychedelics and Drug Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The Psychedelic Therapies Executive Order

Holly Fernandez Lynch, AL McGuire, I Glenn Cohen

Jul 1, 2026

JAMA

Psychedelics and Drug Studies

article

The Psychedelic Therapies Executive Order

Holly Fernandez Lynch, AL McGuire, I Glenn Cohen

July 1, 2026article en

Abstract

This Viewpoint discusses the executive order supporting the development and approval of psychedelic drugs and outlines issues surrounding their ethical and evidence-based integration into clinical care.

JAMA

Baylor College of Medicine (US), Harvard University Press (US), Bioethics International (US), University of Pennsylvania (US)

Good health and well-being

Openalex Percentile: Top 5%

Psychedelics and Drug Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.